Research Reports

Key takeaways

Revenue increased 8.5% to $480.5M from $442.9M, reflecting contributions from acquisitions including Dipsol and favorable foreign exchange impacts as noted in the filing.

Gross profit rose 9.6% to $176.7M with stable 36.8% margin, supporting resilience against sales mix shifts.

Operating income grew 21.6% to $33.6M and operating margin reached 7.0%, demonstrating effective cost management.

Net income surged 52.2% to $19.7M with diluted EPS up 54.8% to $1.13, highlighting improved bottom-line execution.

Operating cash flow turned positive at $3.8M from -$3.1M prior year, though free cash flow was -$6.9M after $10.7M capex for capacity investments.

Full analysis

Profitability strengthened significantly, as gross profit increased 9.6% to $176.7 million, maintaining a 36.8% margin through sales leverage offsetting pressures. Operating income rose 21.6% to $33.6 million (7.0% margin), underscoring disciplined cost controls amid transformation efforts. Net income more than doubled, up 52.2% to $19.7 million, with diluted EPS advancing 54.8% to $1.13, driven by higher operations and equity earnings contributions.

Cash generation improved markedly, with net cash from operating activities flipping to $3.8 million from a $3.1 million outflow last year, signaling better working capital management. However, capital expenditures of $10.7 million resulted in negative free cash flow of -$6.9 million (down from $12.3 million prior), as the company invests in capacity to support growth opportunities including organic investments and possible acquisitions.

KWR · Quaker Chemical Corporation

Summary

Key takeaways

Full analysis